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a b s t r a c t
Objective: Clear cell odontogenic carcinoma (CCOC) is a rare malignant odontogenic tumor (MOT) char-
acterized by sheets and lobules of vacuolated and clear cells. To understand the biology of CCOC, we
established a new cell line, CCOC-T, with EWSR1-ATF1 fusion gene from a mandible tumor with distant
metastasis and characterized this cell line.
Materials and methods: To detect the EWSR1-ATF1 fusion gene, we used three CCOC cases, including the
present case, by RT-PCR and FISH analysis. We characterized established CCOC-T cells by checking cell
growth, invasion and the expression of odontogenic factors and bone-related factors. Moreover, the gene
expression profile of CCOC-T cells was examined by microarray analysis.
Results: Histologically, the primary tumor was comprised of cords and nests containing clear and squa-
moid cells separated by fibrous septa. In addition, ameloblastomatous islands with palisaded peripheral
cells were observed, indicating probable odontogenic origin. This tumor expressed the fusion gene
EWSR1-ATF1, which underlies the etiology of hyalinizing clear cell carcinoma (HCCC) and potentially that
of CCOC. We found a breakpoint in the EWSR1-ATF1 fusion to be the same as that reported in HCCC.
Established CCOC-T cells grew extremely slowly, but the cells showed highly invasive activity.
Moreover, CCOC-T cells expressed bone-related molecules, odontogenic factors, and epithelial mesenchy-
mal transition (EMT)-related molecules.
Conclusion: To the best of our knowledge, this is the first report on the establishment of a CCOC cell line.
CCOC-T cells serve as a useful in vitro model for understanding the pathogenesis and nature of MOT.
! 2017 Elsevier Ltd. All rights reserved.
Introduction
A malignant odontogenic tumor (MOT) is a rare tumor that
comprises up to 2.1% of all odontogenic tumors [1]. Among them,
clear cell odontogenic carcinoma (CCOC) is quite a rare MOT. To
date, 81 cases have been reported in the literature [2–14]. Histo-
logically, CCOC commonly shows a biphasic tumor pattern consist-
ing of large sheets of clear epithelial cells and irregular cords of
basaloid cells with scant eosinophilic cytoplasm, supported by a
fibrous stroma [15]. As clear cell areas are frequently seen in other
oral neoplasms, it is important to rule out these neoplasms of the
oral and maxillofacial regions to obtain a correct diagnosis.
Recently, Bilodeau et al. identified an EWSR1 rearrangement in
five out of six CCOC cases, with confirmation of ATF1 involvement
in one case [16,17]. In addition, a case of CCOC with EWSR1 and
ATF1 rearrangement has been reported [11]. However, the break-
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point of EWSR1-ATF1 fusion has not been clarified in CCOC. Hyalin-
izing clear-cell carcinoma (HCCC) is the first epithelial neoplasm
shown to be associated with EWSR1-ATF1 fusion [18]. HCCC is a
rare minor salivary gland carcinoma composed of clear cells form-
ing cords and nests in a hyalinized stroma [19]. As CCOC and HCCC
have extensive morphologic and immunohistochemical overlap
[20], these two types of tumor are difficult to distinguish histolog-
ically despite a difference in cell origin and location. These findings
suggest that either CCOC represents an intraosseous HCCC or that
CCOC represents an ‘‘odontogenic analogue” to HCCC.
To know the biology and pathogenesis of CCOC, we established
a CCOC cell line with EWSR1-ATF1 fusion and characterized this cell
line.
Materials and methods
Tissue samples
A tissue sample obtained from a CCOC of a 64-year-old Japanese
woman was used for generating a cell line. This study was
approved by the Ethic Committee of Tokushima University
(#1924) and was performed in compliance with the Declaration
of Helsinki. At the time of tissue sampling, we informed the patient
of the use of the tissues for future research and the patient com-
plied. Informed consent was obtained verbally.
To detect the EWSR1-ATF1 fusion gene, we used three CCOC
cases including the present case (obtained from Tokushima
University Hospital and Tokyo Metropolitan Hiroo Hospital), one
HCCC case (obtained from Tokyo Medical University Hospital)
and one oral squamous cell carcinoma (OSCC) case (obtained from
Tokushima University Hospital). Formalin-fixed paraffin-
embedded (FFPE) samples were used after obtaining approval from
the ethics committee of each institution. Informed consent from all
patients was obtained both verbally, as well as written, through a
signature from all patients in this study.
Immunohistochemistry (IHC)
For the IHC analysis of original tumor tissues, paraffin-
embedded sections were deparaffinized and subsequently applied
to heat-induced antigen retrieval in 10 mM citrate buffer (pH 6.0).
The sections were incubated with primary antibody, subsequently
developed using horseradish peroxidase conjugated anti-rabbit
immunoglobulin (Vector Laboratories), and counterstained with
hematoxylin. The antibodies used in this study are listed in Supple-
mentary Table 1.
Fluorescence in situ hybridization (FISH)
FISH analysis of fusion genes was performed with DNA probes
for EWSR1 and ATF1. Unstained sections (4 mm thick) were sub-
jected to hybridization with the EWSR1 break-apart probe kit
(Vysis LSI EWSR1 dual-color, break-apart rearrangement probe;
Abbott Molecular) with bacterial artificial chromosome clone-
derived probes for ATF1 (CTD-2174I21). Hybridized slides were
then stained with DAPI and examined using a BX51 fluorescence
microscope (Olympus).
RT-PCR
Total RNA was obtained from FFPE samples using NucleoSpin"
total RNA FFPE (Macherey-Nagel) and from the cultured cells using
RNeasy Mini kits (Qiagen). The cDNA was synthesized from 1 lg
total RNA using a PrimeScript RT reagent kit (Takara Bio). The pri-
mers used for RT-PCR analysis are listed in Supplementary Table 2.
For detecting EWSR1-ATF1 fusion gene, aliquots of the total cDNA
were amplified with Tks GflexTM DNA Polymerase (Takara Bio),
and amplification was performed in a T100TM thermal cycler (Bio-
rad) for 40 cycles following an initial denaturation at 98 #C for
10 s and 62 #C for 30 s. For conventional RT-PCR, aliquots of the
total cDNA were amplified with Go Taq" Green Master Mix (Pro-
mega), and amplification was performed in a T100TM thermal cycler
for 35 cycles after an initial denaturation at 95 #C for 30 s, an
annealing at 60 #C for 30 s, and an extension at 72 #C for 1 min.
Cell culture
The tissue sample obtained from a CCOC was cut into small
pieces and placed into 90-mm dishes (Falcon) with DMEM
(Sigma-Aldrich) containing 10% fetal bovine serum (FBS) (Gibco).
When these outgrowth cultures formed a confluent monolayer,
the cells were subcultured after enzymatic removal with 0.05%
trypsin-EDTA for the first passage. Then, we subcultured the cells
for over 100 passages and used for the following analyses. A
mucoepidermoid carcinoma (MEC) cell line, NCI-H292, was pur-
chased from American Type Culture Collection and maintained in
RPMI-1640 (Sigma-Aldrich) supplemented with 10% FBS. The OSCC
cell line, HOC313, and an immortalized odontogenic epithelial cell
line, iOdE, were maintained in DMEM supplemented with 10% FBS.
The immortalized ameloblastoma cell line, AM-1, and the immor-
talized gingival epithelial cell line, OBA-9, were maintained in
Keratinocyte-SFM (Invitrogen).
Cytogenetic analysis
Chromosomes were stained with Hoechst 33258. Images were
captured using the Axio Imager 2 (Zeiss). The karyotypes of at least
eight well-banded metaphases were analyzed.
Electron microscopic analysis
The cells were fixed with 2% of paraformaldehyde and 2% glu-
taraldehyde (GA) in 0.1 M phosphate buffer (PB) pH 7.4. Then, they
were fixed with 2% GA in 0.1 M PB at 4 #C overnight. After fixation,
the samples were postfixed in 2% osmium tetroxide with 0.1 M PB
at 4 #C for 1 h. The samples were then dehydrated in graded etha-
nol solutions. Then, the samples were transferred to a resin
(Quetol-812, Nisshin EM Co., Tokyo, Japan) and polymerized at
60 #C for 48 h. The polymerized resins were ultra-thin sectioned
at 70 nm with a diamond knife using an ultramicrotome and the
sections were mounted on copper grids. The ultrathin sections
were double-stained with uranyal acetate and lead citrate. The
grids were observed by a transmission electron microscope (JEM-
1400Plus, JEOL Ltd., Tokyo, Japan) at an acceleration voltage of
80 kV. Digital images (2048 ! 2048 pixels) were taken with a
CCD camera (VELETA, Olympus Soft Imaging Solutions GmbH,
Münster, Germany).
Xenograft
CCOC-T cells (1 ! 106) were resuspended in 50 lL of Cellmatrix
type I-A (Nitta Gelatin, Osaka, Japan), which is an acid-soluble col-
lagen isolated from the tendon of a pig. Cells were injected subcu-
taneously into multiple sites of male SCID mice (CREA Japan Inc.,
Tokyo, Japan). This study was conducted in accordance with the
‘‘Fundamental Guidelines for the Proper Conduct of Animal Exper-
iments and Related Activities in Academic Research Institutions”
under the jurisdiction of the Ministry of Education, Culture, Sports,
Science and Technology of the Japanese Government. This study’s
protocol was approved by the Committee on Animal Experiments
at Tokushima University (#15011). The animals were monitored
S. Kujiraoka et al. / Oral Oncology 69 (2017) 46–55 47
for the formation of a tumor mass every week and were sacrificed
two months later.
In vitro invasion assay
Invasiveness was assessed by an invasion assay using a 24-well
cell culture insert with 8 mm pores (Falcon). The filter was coated
with 20 mg of Matrigel (Becton Dickinson), a reconstituted base-
ment membrane substance. The lower compartment contained
0.5 mL of medium. Following trypsinization, 1.2 ! 105 cells were
resuspended in 100 mL of DMEM supplemented with 10% FBS and
placed in the upper compartment of the cell culture insert for
23 h. At the end of the incubation, the cells were fixed with metha-
nol and stained with hematoxylin. The cells on the upper surface of
the filter were removed by wiping with a cotton swab and the
invasiveness of the cells was determined by counting via a light
microscope at 100! magnification. We performed the assay three
times and three fields were randomly selected for counting for
each assay.
Microarray analysis
The total RNA from the CCOC-T and NCI-H292 cells was isolated
using an RNeasy Mini kit (Qiagen). The RNA quality was first
checked for chemical purity using a NanoDrop spectrophotometer
and then assessed for RNA integrity using the Bioanalyzer 2100
(Agilent Technologies). The total RNA (100 ng) was amplified and
labeled using the Affymetrix Whole-Transcript (WT) Sense Target
Labeling Protocol, and the labeled RNA was hybridized to a Gene-
Chip Human Gene 2.0 ST Array (Affymetrix). Gene expression data
for the iOdE and OBA-9 cells was previously obtained [29]. Data
visualization and analysis was performed using GeneSpring GX
(Version 12.1) software. The accession number for the microarray
dataset reported in this paper is GSE84300.
Results
CCOC case
A 64-year-old Japanese woman was referred for oral surgery for
a radiolucent lesion. Panoramic radiography revealed an irregular-
shaped and partially well-defined radiolucent lesion ranging from
the lower left cuspid to the right retromolar region (Fig. 1A). A CT
scan revealed an osteolytic lesion with a moth-eaten appearance
combined with the disappearance of cortical bone (Fig. 1B). Fluo-
rodeoxyglucose (18F)-PET (FDG-PET) showed abnormal uptake at
the sixth right rib and pubis. With a provisional diagnosis of
MOT, surgical resection of the mandiblular tumor was performed.
The gross examination of the resected specimen revealed a white
tissue mass (Fig. 1C). After surgery, treatment was completed with
chemotherapy. For the metastatic lesion of the rib and pubis, radi-
ation therapy was performed. However, approximately one year
after the surgery, other metastatic lesions were found in the left
clavicle and right scapula.
Histology of CCOC case
The microscopic examination of this case revealed an epithelial
tumor in the mandible consisting of small and irregular sheets or
cords of neoplastic cells separated by dense collagenous stroma
(Fig. 1D and E). The tumor islands were primarily composed of
clear and squamoid cells (Fig. 1D and E). The clear cells contained
various amounts of diastase-digestable PAS-positive granules and
showed no positivity for alcian blue, indicating the glycogen con-
tent of the cytoplasm (Supplementary Table 3). In some areas,
the tumor cells formed a tubular pattern (Fig. 1F). Moreover, the
tumor cells were round to polygonal, had a clear cytoplasm, and
exhibited cellular atypism. The IHC analysis showed that the tumor
cells expressed cytokeratin AE1/AE3, p63, and CK-19 (Fig. 2A–C).
As the differential diagnosis of a jaw tumor with clear cells, CCOC,
intraosseous salivary gland tumors (e.g., MEC, epithelial-
myoepithelial carcinoma, myoepithelial carcinoma, and HCCC),
melanotic tumors, metastatic renal cell carcinoma and the clear-
cell variant of calcifying epithelial odontogenic tumor were raised
[21–24]. Tumor cells were negative for S100, vimentin, EMA, GFAP,
aSMA, HMB-45, UCHL-1, CD10 and CD31 (Supplementary Table 3)
and did not contain amyloid and mucus-producing cells (data not
shown), indicating that the above-mentioned tumors, except for
CCOC and HCCC, were ruled out. As CCOC and HCCC exhibit a mor-
phologic and immunophenotypic overlap [24,25], it was difficult to
distinguish CCOC and intraosseous HCCC. In this tumor, however,
odontogenic features, such as the presence of ameloblastomatous
islands with palisaded peripheral cells and the positivity of CK-
19, were observed (Fig. 2C and D). Finally, this tumor was diag-
nosed as CCOC.
In this tumor, the Ki-67 labeling index was over 30% (Fig. 2E).
Furthermore, neural invasion and necrosis were also observed
(Fig. 2F). Clinically there was metastasis to the sixth right rib,
pubis, left clavicle, and right scapula (Fig. 2G). These findings indi-
cated a high degree of malignancy. Interestingly, this tumor
strongly expressed EGFR, which can be a useful target of anticancer
therapy (Fig. 2H).
EWSR1-ATF1 fusion gene in cases of CCOC
We performed two-color FISH for EWSR1, and ATF1 genes in our
case. Our case showed rearrangement of both EWSR1 and ATF1
genes (Fig. 3A). Then, we confirmed EWSR1-ATF1 fusion transcripts
by RT-PCR from an FFPE sample of this tumor (Fig. 3B). The direct
sequence of the EWSR1-ATF1 fusion transcript revealed that exon
11 of EWSR1 was fused to exon 3 of ATF1 (Fig. 3B), indicating that
the breakpoint is the same as that found in HCCC [18]. Moreover,
we examined the detection of EWSR1-ATF1 fusion transcripts by
RT-PCR from FFPE samples of two other CCOC cases (Case #1 and
#2). An OSCC case (Case #4) was used as a negative control. Infor-
mation and histology regarding the cases used in this experiment
is presented in Fig. 3C, Supplementary Tables 4 and 5. The
EWSR1-ATF1 fusion transcript was detected in all two CCOC cases
(Fig. 3B). As expected, the EWSR1-ATF1 fusion transcript was also
detected in the HCCC case (Case #3), but not in the OSCC case.
Interestingly, we found that Case #1–3 had the same breakpoint
of the EWSR1-ATF1 fusion transcript as observed in our case
(Fig. 3D and Supplementary Table 4).
Establishment of a CCOC cell line
CCOC-T cells were established from the above-mentioned CCOC
case. We subcultured the cells to over P100. CCOC-T cells were
spontaneously immortalized through bypassing senescence with-
out any treatment and exhibited a polygonal shape (Fig. 4A). We
performed a cytogenetic analysis by specifically examining the
conventional karyotype of this cell line. The karyotypes of the
CCOC-T cells were 50, XX, +5, +6, +8, +9, der(9;15)(q10;q10), del
(12)(p12), "13, "16, +add(16)(q24)x2, "22, +mar1, and +mar2
(Fig. 4B). Among twenty cells examined in this analysis, the num-
ber of chromosomes was between 48 and 50 (Fig. 4C).
Upon EM examination of the CCOC-T cells, the tumor cells
exhibited features of squamous cell differentiation, such as
desmosomes with the insertion of tonofilaments (Fig. 4D).
Moreover, the tumor cells demonstrated features of ductal cell
differentiation, such as microvilli formation and intercellular or
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intracytoplasmic lumina formation (Fig. 4E and F). Taken
together, these findings are consistent with the histological fea-
tures in the primary tumor.
CCOC-T cells were then injected subcutaneously with collagen
gel into SCID mice to determine the level of tumor formation
in vivo. After 2 month, tumor was observed, but size was small.
The tumor nests were composed of both squamoid and clear cells
(Fig. 4G). Tumor cells expressed p63, but not S100 (Supplementary
Fig. S1). This result indicates that the tumors formed by the CCOC-T
cells were histologically similar to the primary tumor.
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Fig. 1. A CCOC case. (A) A panoramic radiograph showing the radiolucent lesion (arrows). (B) CT scan image showing the radiolucent lesion (arrows). (C) The macroscopic
finding of the resected specimen. A section of the mandible showing white soft tissue mass (asterisk). R: right, L: left. (D) The tumor consists of small and irregular sheets or
cords of neoplastic cells separated by dense collagenous stroma. (E) Tumor islands are mainly composed of clear cells and squamoid cells. (F) The tumor cells partially form a
tubular pattern.
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Characterization of the CCOC cell line
We next characterized the CCOC-T cells. First, we examined the
growth of the CCOC-T cells. Besides odontogenic carcinoma, MEC
and OSCC also arise in the jaw as an intraosseous type. Therefore,
we used NCI-H292 (MEC) and HOC313 (OSCC) cells in this experi-
ment. NCI-H292 cells contain the CRTC1-MAML2 fusion gene, as
previously reported (Fig. 5A) [26], and HOC313 cells are highly
invasive cancer cells with EMT features [27]. The growth of
CCOC-T cells was extremely slow, in comparison with the
HOC313 and NCI-H292 cells (Fig. 5B). Next, we examined the inva-
sion activity of these cells. The CCOC-T cells demonstrated signifi-
Ki-67
EGFR
E F 
100 μm
100 μm100 μm
100 μm
CK-19
p63 AE1/AE3
C 
A B 
100 μm100 μm
100 μm 100 μm
D 
G H 
Fig. 2. Histological features in CCOC cases. (A) AE1/AE3 staining. Tumor cells are positive for AE1/AE3. (B) p63 staining. Tumor cells are positive for p63. (C) CK-19 staining.
Tumor cells are positive for CK-19. (D) Ameloblastomatous islands with palisaded peripheral cells are observed in the tumor (arrows). (E) Ki-67 staining. The Ki-67 labeling
index is over 30%. (F) Neural invasion in the tumor. (G) Histology of metastatic tumor in right scapula. Metastatic lesion in right scapula was found one year after the
operation of the primary lesion. (H) Expression of EGFR. Tumor cells are positive for EGFR.
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cantly higher invasive activity than the NCI-H292 cells
(Fig. 5C and D). HOC313 cells revealed the highest invasive activity
among all cell types examined.
We examined gene expression in the CCOC-T cells. We con-
firmed the expression of the EWSR1-ATF1 fusion gene in the
CCOC-T cells (Fig. 5A). Then, we examined the expression of
bone-related genes and odotogenic factors including enamel pro-
teins in CCOC-T cells by RT-PCR. CCOC-T cells expressed RUNX2,
BSP, COL1, OCN and MSX2 (Fig. 5E). NCI-H292 cells expressed only
RUNX2. CCOC-T cells expressed amelogenin, amelotin and KLK4,
which are involved in the generation of teeth (Fig. 5F). AM-1 cells
were derived from ameloblastoma, which is a typical odontogenic
tumor [28]. As expected, AM-1 cells expressed enamel proteins
including amelogenin and amelotin (Fig. 5F).
As CCOC-T cells expressed ondontogenic factors, such as amel-
ogenin, amelotin and KLK4, we examined the expression of these
molecules by RT-PCR in FFPE samples of CCOC cases (Cases #1
and #2), and a HCCC case (Case #3) as used in Fig. 2B. Although
amelotin expression was not observed in all cases (data not
shown), amelogenin expression was observed in one of CCOC cases
(Case #2) (Fig. 5G). Moreover, KLK4 expression was observed in all
CCOC cases but not in HCCC (Fig. 5G). These findings suggest that
amelogenin and KLK4 may be used to distinguish between CCOC
and HCCC as an odontogenic marker.
Gene expression profile of the CCOC cell line
To know the specific gene expression in CCOC, we compared the
gene expression profile of CCOC-T and NCI-H292 cells using a
microarray analysis. A total of 326 genes were found to be upreg-
ulated by more than fivefold, while 123 genes were downregulated
by more than fivefold in CCOC-T cells compared with those of the
NCI-H292 cells (Fig. 6A, Supplementary Table 6 and 7). CXCL14,
MMP1, MMP2, MMP8, MMP12, ADAM28, FGF9, S100A7, PTCH1,
CDH11, SNAI2, and N-cadherin were upregulated in CCOC-T cells.
The upregulation of these genes was confirmed by RT-PCR (Fig. 6B).
SNAI2 and N-cadherin are well known EMT-promoting factors.
Therefore, we examined the expression of EMT-related genes,
including SNAI1, E-cadherin and vimentin in CCOC-T cells. While
the upregulation of SNAI1 and N-cadherin was observed, E-
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cadherin downregulation and the upregulation of vimentin were
not observed (Fig. 6B). Several invasion and EMT-related genes
were also found to be upregulated (GSE84300).
Moreover, we compared the gene expression profile of CCOC-T,
NCI-H292, OBA-9 and iOdE. iOdE cells are odontogenic epithelial
cells established from epithelial cell rests of Malassez [29], and
OBA-9 is immortalized gingival epithelial cells. Among them, 183
genes were found to be commonly upregulated in the cell types
of odontogenic origin, CCOC-T and iOdE cells (Fig. 6C and Supple-
mentary Table 8).
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Discussion
Here, the EWSR1-ATF1 fusion transcript was detected in both
CCOC and HCCC cases. Interestingly, exon 11 of EWSR1 was fused
to exon 3 of ATF1 in all CCOC cases, indicating the same breakpoint
found in HCCC [18]. Therefore, the EWSR1-ATF1 fusion gene as well
as histological findings cannot be a distinguishing factor for CCOC
and intraosseous HCCC. Cumulating evidences show that primary
intraosseous salivary gland tumors are extremely rare. However,
two cases of salivary clear cell carcinomas in the mandible which
was distinguished from CCOC by the pattern of histological find-
ings were reported [30]. Several hypotheses have been proposed
to explain the pathogenesis of intraosseous salivary gland tumors.
Although one theory suggests that they may arise from ectopic
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cell counter on days 0, 1, 3, and 5. (C) Invasion activity was examined by an in vitro invasion assay with CCOC-T, NCI-H292, and HOC313 cells. Figures show the representative
area of the penetrated cells. (D) The graph shows the average number of penetrated cells in an in vitro invasion assay with CCOC-T, NCI-H292, and HOC313 cells. The bars
show the average values and SDs of three independent experiments. *P < 0.05. (E) Expression of bone-related genes in CCOC-T cells. Expression of bone-related genes
including RUNX2, ALP, BSP, COLI, OCN, and MSX2 was examined by RT-PCR in CCOC-T and NCI-H292 cells. GAPDH was used as a loading control. (F) Expression of
odontogenic factors in CCOC-T cells. Expression of odontogenic factors including amelogenein, AMBN, amelotin, KLK4, MMP-20, and ODAM was examined by RT-PCR in
CCOC-T, NCI-H292 and AM-1 cells. GAPDH was used as a loading control. (G) Expression of amelogenein, amelotin, and KLK4 in FFPE samples of CCOC and HCCC cases. FFPE
samples were used in Fig. 2F. FFPE samples of Case #1 and #2 (CCOC), and Case #3 (HCCC) were used. CCOC-T cells were used as positive control. GAPDH was used as a
loading control.
S. Kujiraoka et al. / Oral Oncology 69 (2017) 46–55 53
salivary gland tissue that was developmentally entrapped within
the jaw, the discovery of ectopic salivary gland tissue is extremely
rare in biopsy specimens from the jaw [31]. Therefore, this seems
unlikely source for intraosseous salivary gland tumors. The most
likely source for intraosseous tumors is odontogenic epithelium.
Indeed, mucous-producing cells and glandular structure are fre-
quently found in the lining epithelium of odontogenic cysts. In
our case, ameloblastomatous islands with palisaded peripheral
cells were observed, suggesting the evidence of an odontogenic ori-
gin. These findings suggest that it is difficult to understand that a
rare salivary gland carcinoma, HCCC develops in the jaw. Therefore,
CCOC represents an ‘‘odontogenic analogue” to HCCC. In addition,
the expression of odontogenic factors and bone-related genes were
observed in CCOC-T cells. Our microarray analyses revealed that
183 genes are commonly upregulated in CCOC-T cells and immor-
talized odontogenic epithelial cells among other type of cells
including gingival epithelial cells and salivary gland tumor cells.
This finding may help to identify the specific marker for CCOC.
Moreover, we examined the karyotypes of the CCOC-T cells and
found that the CCOC-T cells have a translocation (9;15)(q10;q10)
and deletion of chromosome 12, suggesting that a specific abnor-
mality may exist in CCOC. However, to identify the specific factors
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Fig. 6. Gene expression profile of CCOC-T cells. (A) Comparison of the gene expression profiles between CCOC-T cells and NCI-H292 cells by a microarray analysis. Scatter plot
of CCOC-T cells (x axis) and NCI-H292 cells (y axis). The green lines indicate a twofold upregulation or downregulation. (B) Upregulated genes in CCOC-T cells by a microarray
analysis (CXCL14, MMP1, MMP2, MMP8, MMP12, ADAM28, FGF9, S100A7, PTCH1, CDH11, N-cadherin and SNAI2) were confirmed by RT-PCR. EMT-related genes, such as
SNAI1, E-cadherin, and vimentin were also examined by RT-PCR. GAPDH was used as a loading control. (C) Comparison of the gene expression profile of CCOC-T cells with that
of NCI-H292, OBA-9 and iOdE cells. The graph shows the heat map of the gene expression among CCOC-T, NCI-H292, OBA-9 and iOdE cells. Commonly upregulated genes in
the cell types of odontogenic origin (CCOC-T and iOdE cells) are highlighted and listed in Supplementary Table 8.
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of CCOC for a differential diagnosis, further experiments are
required.
The CCOC-T cells demonstrated enhanced invasiveness and the
expression of several MMPs and EMT-promoting factors. This phe-
notype is consistent with the finding that the primary tumor
exhibited malignant behaviors, such as perineural invasion and
distant metastasis. Similar to other malignant tumors, EMT may
play an important role in the malignant behaviors of CCOC. Inter-
estingly, this tumor strongly expressed EGFR (Fig. 2H). Although
there is no report on EGFR expression in odontogenic carcinoma,
EGFR inhibitors may be used for the chemotherapy against odonto-
genic carcinoma including CCOC.
In summary, we established a CCOC cell line (CCOC-T) that
exhibited the presence of the EWSR1-ATF1 fusion gene, odonto-
genic features, and highly invasive activity. This is the first report
regarding the establishment of a CCOC cell line. We believe that
CCOC-T cells can be a useful cellular model for understanding the
pathogenesis and nature of MOT including CCOC. Moreover,
CCOC-T cells may facilitate the discovery of diagnostic makers for
the differential diagnosis of this type of cancer.
Conflict of interest statement
All contributing authors declare no conflicts of interest.
Acknowledgements
This study was supported by a Grant-in-Aid from the Ministry
of Education, Science, and Culture of Japan. Technical assistance
was provided from the Support Center for Advanced Medical
Sciences (Tokushima University). The authors thank Mr. Hideaki
Horikawa (Tokushima University) for technical assistance and Dr.
Ikuko Ogawa (Hiroshima University) for valuable discussion. The
authors also thank Dr. Shigehiro Abe and Dr. Naoko Yokomizo
(Hiroo hospital) for providing clinical information. In addition,
the authors thank Dr. Nobuyuki Kamata (Hiroshima University),
Dr. Harada (Iwate Medical University), and Dr. Shinya Murakami
(Osaka University) for kindly providing HOC313, AM-1, and OBA-
9 cells, respectively.
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.oraloncology.
2017.04.003.
References
[1] Bang G, Koppang HS, Hansen LS, Gilhuus-Moe O, Aksdal E, Persson PG, et al.
Clear cell odontogenic carcinoma: report of three cases with pulmonary and
lymph node meatastasis. J Oral Pathol Med 1989;18:113–8.
[2] Servato JP, Prieto-Oliveira P, de Faria PR, Loyola AM, Cardoso SV. Odontogenic
tumours: 240 cases diagnosed over 31 years at a Brazilian university and a
review of international literature. Int J Oral Maxillofac Surg 2013;42:288–93.
[3] Fan J, Kubota E, Imamura H, Shimokama T, Tokunaga O, Katsuki T, et al. Clear
cell odontogenic carcinoma: a case report with massive invasion of
neighboring organs and lymph node metastasis. Oral Surg Oral Med Oral
Pathol 1992;74:768–75.
[4] Milles M, Doyle J, Mesa M, Raz S. Clear cell odontogenic carcinoma with lymph
node metastasis. Oral Surg Oral Med Oral Pathol 1993;76:82–9.
[5] Li TJ, Yu SF, Gao Y, Wang EB. Clear cell odontogenic carcinoma: a
clinicopathologic and immunocytochemical study of 5 cases. Arch Pathol Lab
Med 2001;125:1566–71.
[6] Zhang J, Liu L, Pan J, Tian X, Tan J, Zhou J, et al. Clear cell odontogenic
carcinoma: report of 6 cases and review of the literature. Med Oncol 2011;28:
S626–33.
[7] Yazici ZM, Mete O, Elmali Z, Sayin I, Yilmazer R, Kayhan FT. Clear cell
odontogenic carcinoma of the maxilla. Acta Med (Hradec Kralove)
2011;54:122–4.
[8] Infante-Cossio P, Torres-Carranza E, Gonzalez-Perez LM, Gonzalez-Cardero E,
Sanchez-Gallego F. Atypical presentation of clear cell odontogenic carcinoma. J
Craniofac Surg 2012;23:e466–8.
[9] Swain N, Dhariwal R, Ray JG. Clear cell odontogenic carcinoma of maxilla: a
case report and mini review. J Oral Maxillofac Pathol 2013;17:89–94.
[10] Kalsi AS, Williams SP, Shah KA, Fasanmade A. Clear cell odontogenic
carcinoma: a rare neoplasm of the maxillary bone. J Oral Maxillofac Surg
2014;72:935–8.
[11] Yancoskie AE, Sreekantaiah C, Jacob J, Rosenberg A, Edelman M, Antonescu CR,
et al. EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma:
presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:
e115–8.
[12] Krishnamoorthy R, Ravi Kumar AS, Batstone M. FDG-PET/CT in staging of clear
cell odontogenic carcinoma. Int J Oral Maxillofac Surg 2014;43:1326–9.
[13] Kim M, Cho E, Kim JY, Kim HS, Nam W. Clear cell odontogenic carcinoma
mimicking a cystic lesion: a case of misdiagnosis. J Korean Assoc Oral
Maxillofac Surg 2014;40:199–203.
[14] Kwon IJ, Kim SM, Amponsah EK, Myoung H, Lee JH, Lee SK. Mandibular clear
cell odontogenic carcinoma. World J Surg Oncol 2015;13:284.
[15] Ban G, Koppang H. Odontogenic clear cell carcinoma. In: Barnes L, Eveson JW,
Reichart P, Sidransky D, editors. World health organization classification of
tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press;
2005. p. 292.
[16] Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, et al. Clear
cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding
and a biologic link to salivary clear cell carcinomas. Am J Surg Pathol
2013;37:1001–5.
[17] Tanguay J, Weinreb I. What the EWSR1-ATF1 fusion has taught us about
hyalinizing clear cell carcinoma. Head Neck Pathol 2013;7:28–34.
[18] Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, et al.
EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell
carcinoma of salivary gland. Genes Chromosomes Cancer 2011;50:559–70.
[19] Milchgrub S, Gnepp DR, Vuitch F, Delgado R, Albores-Saavedra J. Hyalinizing
clear cell carcinoma of salivary gland. Am J Surg Pathol 1994;18:74–82.
[20] Bilodeau EA, Hoschar AP, Bames EL, Hunt JL, Seethala RR. Clear cell carcinoma
and clear cell odontogenic carcinoma: a comparative clinicopathologic and
immunohistochemical study. Head Neck Pathol 2011;5:101–7.
[21] Iezzi G, Rubini C, Fioroni M, Piattelli A. Clear cell odontogenic carcinoma. Oral
Oncol 2002;38:209–13.
[22] Mosqueda-Taylor A, Meneses-Garcia A, Ruiz-Godoy Rivera LM, de Lourdes
Suárez-Roa M. Clear cell odontogenic carcinoma of the mandible. J Oral Pathol
Med 2002;31:439–41.
[23] Piattelli A, Sesenna E, Trisi P. Clear cell odontogenic carcinoma. Report of a case
with lymph node and pulmonary metastases. Eur J Cancer B Oral Oncol
1994;30B:278–80.
[24] Brandwein M, Said-Al-Naief N, Gordon R, Urken M. Clear cell odontogenic
carcinoma: report of a case and analysis of the literature. Arch Otolaryngol
Head Neck Surg 2002;128:1089–95.
[25] Weinreb I. Hyalinizing clear cell carcinoma of salivary gland: a review and
update. Head Neck Pathol 2013;7:S20–9.
[26] Amelio AL, Fallahi M, Schaub FX, Zhang M, Lawani MB, Alperstein AS, et al.
CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature
predictive of cancers with CREB-MYC involvement. Proc Natl Acad Sci USA
2014;111:E3260–8.
[27] Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T. N-cadherin
expression is involved in malignant behavior of head and neck cancer in
relation to epithelial-mesenchymal transition. Histol Histopathol
2011;26:147–56.
[28] Harada H, Mitsuyasu T, Nakamura N, Higuchi Y, Toyoshima K, Taniguchi A,
et al. Establishment of ameloblastoma cell line, AM-1. J Oral Pathol Med
1998;27:207–12.
[29] Tsunematsu T, Fujiwara N, Yoshida M, Takayama Y, Kujiraoka S, Qi G, et al.
Human odontogenic epithelial cells derived from epithelial rests of Malassez
possesses stem cell properties. Lab Invest 2016;96:1063–75.
[30] Berho M, Huvos AG. Central hyalinizing clear cell carcinoma of the mandible
and the maxilla a clinicopathologic study of two cases with an analysis of the
literature. Hum Pathol 1999;30:101–5.
[31] Bouquot JE, Gnepp DR, Dardick I, Hietanen JH. Intraosseous salivary tissue:
jawbone examples of choristomas, hamartomas, embryonic rests, and
inflammatory entrapment: another histogenetic source for intraosseous
adenocarcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2000;90:205–17.
S. Kujiraoka et al. / Oral Oncology 69 (2017) 46–55 55
